Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-20 Risser Eric Blasius Sr VP & Chief Business Officer Sale −3,000 $18.38 $55K 30,806
2019-05-20 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −3,000 7,653
2019-05-16 SIEGEL JAY PHILIP Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Ferrante Karen Jean Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Ferrante Karen Jean Director Grant or award · Stock Option (right to buy) +4,616 4,616
2019-05-16 Galbraith Kenneth Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Costa Paulo F Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Costa Paulo F Director Grant or award · Stock Option (right to buy) +7,357 7,357
2019-05-16 HURWITZ EDWARD Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 STUMP DAVID C Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Jackson Scott Thomas Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-05-16 Fust Matthew K Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-03-14 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +2,497 $0.94 $2K 30,806
2019-03-14 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −2,497 0
2019-02-21 Risser Eric Blasius Sr VP & Chief Business Officer Grant or award · Employee stock option (right to buy) +85,000 85,000
2019-02-21 Spitznagel Thomas Sr VP, BPD & Manufacturing Grant or award · Employee stock option (right to buy) +70,000 70,000
2019-02-21 Karrels James SVP, CFO and Secretary Grant or award · Employee stock option (right to buy) +85,000 85,000
2019-02-21 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Grant or award · Employee stock option (right to buy) +90,000 90,000
2019-02-21 Cilinski Lynn VP, Controller and Treasurer Grant or award · Employee stock option (right to buy) +35,000 35,000
2019-02-21 Bonvini Ezio Sr VP, Research & CSO Grant or award · Employee stock option (right to buy) +90,000 90,000

Page 29 of 35 · 684 trades